Skip to main content

Table 3 Subgroup analysis of liver cirrhosis and HBsAg

From: Prognostic and clinicopathological value of Beclin-1 expression in hepatocellular carcinoma: a meta-analysis

Subgroups No. of studies Pooled OR (95% CI) P value Heterogeneity
I 2 P value
Liver cirrhosis
 Asia 6 1.27 (0.72–2.25) 0.42 42% 0.12
 Egypt 2 10.03 (0.74–136.23) 0.08 63% 0.10
HBsAg
 Asia 6 0.91 (0.61–1.34) 0.62 38% 0.15
 Egypt 1 0.24 (0.06–0.97) 0.04
  1. HBsAg hepatitis B surface antigen, OR odds ratio, CI confidence interval